Project Grant K23HL186243
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Kaiser Foundation Hospitals $3.92 million through the Cardiovascular Diseases Research program (CFDA 93.837) on September 27, 2025, for the HIDDEN-ASCVD (Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of Atherosclerotic Cardiovascular Disease) Study, with completion scheduled for August 31, 2029. The project leverages deep...
- Federal Grant Award Summary Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute division, received a $1.758 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). Awarded on July 15, 2026, with an ultimate completion date of June 30, 2028, this ancillary study to the Women's Health Initiative will characterize postmenopausal androgen and sex hormone binding globulin...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $722,299 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2030. This award funds a research initiative applying deep learning models to quantify aortic valve measurements in 100,000 UK Biobank participants to identify shared genetic and epidemiological factors underlying normal...
- Federal Project Grant Award Summary Kaiser Foundation Hospitals' Kaiser Foundation Research Institute received a $751,124 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) awarded on September 15, 2025, with completion targeted for June 30, 2030. The grant funds research investigating optimal physical activity (PA) timing, intensity, and 24-hour activity composition for the prevention of hypertensive...
- Federal Project Grant Summary Kaiser Foundation Hospitals (Kaiser Permanente), through its Kaiser Foundation Research Institute, received a $743,492 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 5, 2025, with completion scheduled for June 30, 2029. The grant funds a longitudinal cohort study examining the effects of HIV pre-exposure prophylaxis (PrEP), specifically tenofovir-based...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $169,344 Project Grant to the University of California, Davis, effective August 1, 2025, through July 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This K23 career development award supports research applying digital phenotypes and epigenetics to understand clinical outcomes in non-acute respiratory distress syndrome acute hypoxemic respiratory failure (NAHRF). The...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Geisinger Clinic $727,665 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 15, 2026, to improve the detection and understanding of aortic aneurysms through large-scale radiologic and genetic risk assessments. The project, set to conclude on March 31, 2030, will utilize deep learning-based automated analysis of existing radiologic images to enhance detection and measurement of...
- Federal Grant Award Summary Brigham and Women's Hospital Inc. received a $167,400 Project Grant awarded July 15, 2026, by the National Heart, Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant funds a five-year research initiative (completion date June 30, 2031) to conduct a multi-omic evaluation of calcific aortic valve disease (CAVD), specifically distinguishing between atherogenic and non-atherogenic mechanisms. The research employs...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $246,000 to the University of California, San Francisco (UCSF) under the Cardiovascular Diseases Research program (CFDA 93.837) on July 6, 2026, with a completion date of June 30, 2028. This R21 resubmission leverages UCSF's existing Ventricular Tachycardia (VT) Database—a comprehensive, expertly annotated dataset encompassing 5,679 consecutive intensive care unit (ICU) patients with 572,574 hours...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $177,814 to the University of California, San Diego on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate smartphone-based digital biomarkers for detecting peripheral artery disease (PAD) and coronary artery disease (CAD). The project, scheduled for completion by June 30, 2031, leverages photoplethysmography (PPG) technology integrated into mobile...
Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute in Pleasanton, California, received a $193,055 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) on July 15, 2026. The award supports a K23 career development grant facilitating Dr. Vy Ho's transition to an independent surgeon-informaticist specializing in abdominal aortic aneurysm (AAA) diagnosis, surveillance, and treatment. The project delivers machine learning-based tools and clinical training to address critical gaps in AAA screening and diagnosis, particularly among underrepresented patient populations including women and non-smokers. Key deliverables include development of machine learning algorithms to predict AAA risk from electronic health records; formal training in computer vision for cardiovascular risk prediction, AAA risk factors in underrepresented populations, and decision curve analysis; quantification of current AAA diagnostic performance; and stakeholder-informed intervention strategies to optimize real-world clinical implementation. The award supports the recipient through the project completion date of June 30, 2031, leveraging Kaiser Permanente's integrated healthcare delivery infrastructure, comprehensive electronic health records across 4.5 million diverse members, and established research capabilities in cardiovascular disease research and implementation science.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $193.1k | 7/10/26 |